Trabajos de Manuel Cobo

Clinical Medicine


  Listando 42 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   17   News   0   Policy
Article Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial Provencio, Mariano; Nadal, Ernest; Insa, Amelia; Rosario Garcia-Campelo, Maria; Casal-Rubio, Joaquin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manuel; Lopez Vivanco, Guillermo; del Ba LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(20)30453-8
Mentions   0   Wikipedia   23   News   1   Policy
Article Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC Ramalingam, S. S.; Vansteenkiste, J.; Planchard, D.; Cho, B. C.; Gray, J. E.; Ohe, Y.; Zhou, C.; Reungwetwattana, T.; Cheng, Y.; Chewaskulyong, B.; Shah, R.; Cobo, M.; Lee, K. H.; Cheema, P.; Tiseo, M.; John, T.; Lin, M-C; Imamura, F.; Kurata, T.; Todd, A. NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2020) DOI / 10.1056/nejmoa1913662 Bronze
Mentions   1   Wikipedia   13   News   0   Policy
Article Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial Janne, Pasi A.; van den Heuvel, Michel M.; Barlesi, Fabrice; Cobo, Manuel; Mazieres, Julien; Crino, Lucio; Orlov, Sergey; Blackhall, Fiona; Wolf, Juergen; Garrido, Pilar; Poltoratskiy, Artem; Mariani, Gabriella; Ghiorghiu, Dana; Kilgour, Elaine; Smith, Pau JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 0098-7484 (2017) DOI / 10.1001/jama.2017.3438 Green published
Mentions   0   Wikipedia   10   News   0   Policy
Article First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souqu LANCET ONCOLOGY 1470-2045 (2021) DOI / 10.1016/s1470-2045(20)30641-0
Mentions   0   Wikipedia   8   News   0   Policy
Article CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Reungwetwattana, Thanyanan; Nakagawa, Kazuhiko; Cho, Byoung Chul; Cobo, Manuel; Cho, Eun Kyung; Bertolini, Alessandro; Bohnet, Sabine; Zhou, Caicun; Lee, Ki Hyeong; Nogami, Naoyuki; Okamoto, Isamu; Leighl, Natasha; Hodge, Rachel; McKeown, Astrid; Brown, An JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2018.78.3118
Mentions   0   Wikipedia   2   News   0   Policy
Article Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer The MYSTIC Phase 3 Randomized Clinical Trial Rizvi, Naiyer A.; Cho, Byoung Chul; Reinmuth, Niels; Lee, Ki Hyeong; Luft, Alexander; Ahn, Myung-Ju; van den Heuvel, Michel M.; Cobo, Manuel; Vicente, David; Smolin, Alexey; Moiseyenko, Vladimir; Antonia, Scott J.; Le Moulec, Sylvestre; Robinet, Gilles; Na JAMA ONCOLOGY 2374-2437 (2020) DOI / 10.1001/jamaoncol.2020.0237 Gold other, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial Goss, Glenwood D.; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Li, WEI; Guclu, Salih; Isla, Dolores; Min, Young Joo; Morabito, Alessandro; Ardizzoni, Andrea; Gadgeel, Shirish M.; Fue JAMA ONCOLOGY 2374-2437 (2018) DOI / 10.1001/jamaoncol.2018.0775 Green published, Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy Casarrubios, Marta; Cruz-Bermudez, Alberto; Nadal, Ernest; Insa, Amelia; Garcia Campelo, Maria del Rosario; Lazaro, Martin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; de Castro-Carpeno, Javier; Cobo, Manuel; Lopez-Viva CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-1200
Mentions   0   Wikipedia   1   News   0   Policy
Article SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) Domine, M.; Moran, T.; Isla, D.; Marti, J. L.; Sullivan, I.; Provencio, M.; Olmedo, M. E.; Ponce, S.; Blasco, A.; Cobo, M. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02295-w Gold other
Mentions   0   Wikipedia   2   News   0   Policy
Article CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations Felip, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Cobo, Manuel; Laktionov, Konstantin; Szilasi, Maria; Califano, Raffaele; Carcereny, Enric; Griffiths, Richard; Paz-Ares, Luis; Duchnowska, Renata; Alonso Garcia, Miriam; Isla, Dolores; Jassem, Jacek; Ap EUROPEAN JOURNAL OF CANCER 0959-8049 (2020) DOI / 10.1016/j.ejca.2019.11.019 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial Romero, Atocha; Jantus-Lewintre, Eloisa; Garcia-Pelaez, Beatriz; Royuela, Ana; Insa, Amelia; Cruz, Patricia; Collazo, Ana; Perez Altozano, Javier; Vidal, Oscar Juan; Diz, Pilar; Cobo, Manuel; Hernandez, Berta; Vazquez Estevez, Sergio; Benitez, Gretel; Guir MOLECULAR ONCOLOGY 1574-7891 (2020) DOI / 10.1002/1878-0261.12832 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial Laza-Briviesca, Raquel; Cruz-Bermudez, Alberto; Nadal, Ernest; Insa, Amelia; Garcia-Campelo, Maria del Rosario; Huidobro, Gerardo; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manuel; Lop CLINICAL AND TRANSLATIONAL MEDICINE 2001-1326 (2021) DOI / 10.1002/ctm2.491 Green published, Gold
Mentions   0   Wikipedia   3   News   0   Policy
Article Evaluation of the VeriStrat (R) serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study Gadgeel, Shirish; Goss, Glenwood; Soria, Jean-Charles; Felip, Enriqueta; Georgoulias, Vassilis; Lu, Shun; Cobo, Manuel; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Guclu, Salih Z.; Isla, Dolores; Morabito, Alessandro; Dupuis, Nicholas; Buehnemann, LUNG CANCER 0169-5002 (2017) DOI / 10.1016/j.lungcan.2017.05.010 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial Sierra-Rodero, Belen; Cruz-Bermudez, Alberto; Nadal, Ernest; Garitaonaindia, Yago; Insa, Amelia; Mosquera, Joaquin; Casal-Rubio, Joaquin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manu JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021) DOI / 10.1136/jitc-2021-002804
Mentions   0   Wikipedia   2   News   0   Policy
Article Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Gray, Jhanelle E.; Okamoto, Isamu; Sriuranpong, Virote; Vansteenkiste, Johan; Imamura, Fumio; Lee, Jong Seok; Pang, Yong-Kek; Cobo, Manuel; Kasahara, Kazuo; Cheng, Ying; Nogami, Naoyuki; Cho, Eun Kyung; Su, Wu Chou; Zhang, Guili; Huang, Xiangning; Li-Sucho CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-19-1126 Green accepted, Bronze
Mentions   0   Wikipedia   2   News   0   Policy
Article ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC) Morgensztern, Daniel; Cobo, Manuel; Aix, Santiago Ponce; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Juergen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot CANCER 0008-543X (2018) DOI / 10.1002/cncr.31779 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study Provencio, Mariano; Rodriguez-Abreu, Delvys; Ortega, Ana L.; Serrano, Gloria; Aguado, Carlos; Franco, Fernando; Gutierrez, Vanesa; Lopez Vivanco, Guillermo; Guirado, Maria; Benitez, Gretel; Estival, Anna; Calvo, Virginia; Jimenez, Beatriz; Arasanz, Hugo; C TRANSLATIONAL LUNG CANCER RESEARCH 2218-6751 (2021) DOI / 10.21037/tlcr-21-504 Gold
Mentions   0   Wikipedia   1   News   0   Policy
Article Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer Fehrenbacher, Louis; von Pawel, Joachim; Park, Keunchil; Rittmeyer, Achim; Gandara, David R.; Aix, Santiago Ponce; Han, Ji-Youn; Gadgeel, Shirish M.; Hida, Toyoaki; Cortinovis, Diego L.; Cobo, Manuel; Kowalski, Dariusz M.; de Marinis, Filippo; Gandhi, Maya JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2018) DOI / 10.1016/j.jtho.2018.04.039 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry Franco, Fernando; Carcereny, Enric; Guirado, Maria; Ortega, Ana L.; Lopez-Castro, Rafael; Rodriguez-Abreu, Delvys; Garcia-Campelo, Rosario; del Barco, Edel; Juan, Oscar; Aparisi, Francisco; Gonzalez-Larriba, Jose L.; Domine, Manuel; Trigo, Jose M.; Cobo, M PLOS ONE 1932-6203 (2021) DOI / 10.1371/journal.pone.0251761 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Lung cancer symptoms at diagnosis: results of a nationwide registry study Ruano-Ravina, Alberto; Provencio, Mariano; Calvo de Juan, Virginia; Carcereny, Enric; Moran, Teresa; Rodriguez-Abreu, Delvys; Lopez-Castro, Rafael; Cuadrado Albite, Eugenio; Guirado, Maria; Gomez Gonzalez, Lucia; Massuti, Bartomeu; Ortega Granados, Ana Lau ESMO OPEN (2020) DOI / 10.1136/esmoopen-2020-001021 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non-small-cell Lung Cancer: LAURA Trial in Progress Lu, Shun; Casarini, Ignacio; Kato, Terufumi; Cobo, Manuel; Ozguroglu, Mustafa; Hodge, Rachel; van der Gronde, Toon; Saggese, Matilde; Ramalingam, Suresh S. CLINICAL LUNG CANCER 1525-7304 (2021) DOI / 10.1016/j.cllc.2020.11.004
Mentions   0   Wikipedia   0   News   0   Policy
Article Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group Provencio, Mariano; Terrasa, Josefa; Garrido, Pilar; Garcia Campelo, Rosario; Aparisi, Francisco; Diz, Pilar; Aguiar, David; Garcia-Giron, Carlos; Hidalgo, Julia; Aguado, Carlos; Garcia Gonzalez, Jorge; Esteban, Emilio; Gomez-Aldavari, Lorenzo; Moran, Tere BMC CANCER (2021) DOI / 10.1186/s12885-021-07922-5 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study Ruano-Ravina, Alberto; Provencio, Mariano; Calvo de Juan, Virginia; Carcereny, Enric; Estival, Anna; Rodriguez-Abreu, Delvys; Benitez, Gretel; Lopez-Castro, Rafael; Belver, Marta; Guirado-Risueno, Maria; Guirao-Rubio, Carlos; Blasco, Ana; Massuti, Bartomeu TRANSLATIONAL LUNG CANCER RESEARCH 2218-6751 (2021) DOI / 10.21037/tlcr-21-559 Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update Reck, M.; Ciuleanu, T. -E.; Cobo, M.; Schenker, M.; Zurawski, B.; Menezes, J.; Richardet, E.; Bennouna, J.; Felip, E.; Juan-Vidal, O.; Alexandru, A.; Sakai, H.; Lingua, A.; Reyes, F.; Souquet, P. -J.; De Marchiy, P.; Martin, C.; Perol, M.; Scherpereel, A.; ESMO OPEN (2021) DOI / 10.1016/j.esmoop.2021.100273 Green published, Gold
Mentions   0   Wikipedia   1   News   0   Policy
Article Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer Sequist, Lecia, V; Gray, Jhanelle Elaine; Harb, Wael A.; Lopez-Chavez, Ariel; Doebele, Robert C.; Modiano, Manuel R.; Jackman, David Michael; Baggstrom, Maria Quintos; Atmaca, Akin; Felip, Enriqueta; Provencio, Mariano; Cobo, Manuel; Adiwijaya, Bambang; Ku ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2018-0695 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial Gridelli, Cesare; Ciuleanu, Tudor; Domine, Manuel; Szczesna, Aleksandra; Bover, Isabel; Cobo, Manuel; Kentepozidis, Nikolaos; Zarogoulidis, Konstantinos; Kalofonos, Charalabos; Kazarnowisz, Andrzej; Korozan, Magdalena; De Las Penas, Ramon; Majem, Margarita BRITISH JOURNAL OF CANCER 0007-0920 (2020) DOI / 10.1038/s41416-020-0785-y
Mentions   0   Wikipedia   0   News   0   Policy
Article Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial Nishio, Makoto; Barlesi, Fabrice; West, Howard; Ball, Simon; Bordoni, Rodolfo; Cobo, Manuel; Longeras, Pascale Dubray; Goldschmidt, Jerome, Jr.; Novello, Silvia; Orlandi, Francisco; Sanborn, Rachel E.; Szalai, Zsuzsanna; Ursol, Grigoriy; Mendus, Diana; Wan JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2021) DOI / 10.1016/j.jtho.2020.11.025 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA Brown, Helen; Vansteenkiste, Johan; Nakagawa, Kazuhiko; Cobo, Manuel; John, Thomas; Barker, Craig; Kohlmann, Alexander; Todd, Alexander; Saggese, Matilde; Chmielecki, Juliann; Markovets, Aleksandra; Scott, Marietta; Ramalingam, Suresh S. JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2020) DOI / 10.1016/j.jtho.2019.09.009 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy De Castro, J.; Gonzalez-Larriba, J. L.; Vazquez, S.; Massuti, B.; Sanchez-Torres, J. M.; Domine, M.; Garrido, P.; Calles, A.; Artal, A.; Collado, R.; Garcia, R.; Sereno, M.; Majem, M.; Macias, J. A.; Juan, O.; Gomez-Codina, J.; Hernandez, B.; Lazaro, M.; O CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1527-8
Mentions   0   Wikipedia   0   News   0   Policy
Article Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study von Pawel, J.; Bordoni, R.; Satouchi, M.; Fehrenbacher, L.; Cobo, M.; Han, J. Y.; Hida, T.; Moro-Sibilot, D.; Conkling, P.; Gandara, D. R.; Rittmeyer, A.; Gandhi, M.; Yu, W.; Matheny, C.; Patel, H.; Sandler, A.; Ballinger, M.; Kowanetz, M.; Park, K. EUROPEAN JOURNAL OF CANCER 0959-8049 (2019) DOI / 10.1016/j.ejca.2018.11.020
Mentions   0   Wikipedia   0   News   0   Policy
Article First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met Majem, Margarita; Sullivan, Ivanna; Viteri, Santiago; Lopez-Vivanco, Guillermo; Cobo, Manuel; Sanchez, Jose M.; Garcia-Gonzalez, Jorge; Garde, Javier; Sampayo, Miguel; Martrat, Griselda; Malfettone, Andrea; Karachaliou, Niki; Molina-Vila, Miguel A.; Rosell EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.09.039
Mentions   0   Wikipedia   0   News   0   Policy
Review Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response Xiao, Qingyang; Nobre, Andre; Pineiro, Pilar; Berciano-Guerrero, Miguel-Angel; Alba, Emilio; Cobo, Manuel; Lauschke, Volker M.; Barragan, Isabel JOURNAL OF CLINICAL MEDICINE (2020) DOI / 10.3390/jcm9010286 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC Nishio, Makoto; Felip, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming; Cobo, Manuel; McKeage, Mark; Su, Wu-Chou; Mok, Tony; Scagliotti, Giorgio V.; Spigel, David R.; Viraswami-Appanna, Kalyanee; Chen, Zhe; Passos, Vanessa Q.; Shaw JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2020) DOI / 10.1016/j.jtho.2019.11.006 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review A consensus statement on the gender perspective in lung cancer Isla, D.; Majem, M.; Vinolas, N.; Artal, A.; Blasco, A.; Felip, E.; Garrido, P.; Remon, J.; Baquedano, M.; Borras, J. M.; Die Trill, M.; Garcia-Campelo, R.; Juan, O.; Leon, C.; Lianes, P.; Lopez-Rios, F.; Molins, L.; Planchuelo, M. A.; Cobo, M.; Paz-Ares, CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1578-x Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study Ruiz-Medina, Sofia; Gil, Silvia; Jimenez, Begona; Rodriguez-Brazzarola, Pablo; Diaz-Redondo, Tamara; Cazorla, Mireya; Munoz-Ayllon, Marta; Ramos, Inmaculada; Reyna, Carmen; Jose Bermejo, Maria; Godoy, Ana; Torres, Esperanza; Cobo, Manuel; Galvez, Laura; Ru CANCERS (2021) DOI / 10.3390/cancers13133215 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial Goss, Glenwood D.; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Georgoulias, Vassilis; Isla, Dolores; Morabito, Alessandro; Min, Young J.; Ardizzoni, Andrea; Bender, Shaun; Cseh, Agnieszka; Felip, Enriqueta ECLINICALMEDICINE (2021) DOI / 10.1016/j.eclinm.2021.100940 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy Felip, Enriqueta; Hirsh, Vera; Popat, Sanjay; Cobo, Manuel; Fulop, Andrea; Dayen, Charles; Trigo, Jose M.; Gregg, Richard; Waller, Cornelius F.; Soria, Jean-Charles; Goss, Glenwood D.; Gordon, James; Wang, Bushi; Palmer, Michael; Ehrnrooth, Eva; Gadgeel, S CLINICAL LUNG CANCER 1525-7304 (2018) DOI / 10.1016/j.cllc.2017.06.002 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors Nadal, Ernest; Massuti, Bartomeu; Domine, Manuel; Garcia-Campelo, Rosario; Cobo, Manuel; Felip, Enriqueta CANCER IMMUNOLOGY IMMUNOTHERAPY 0340-7004 (2019) DOI / 10.1007/s00262-019-02310-2
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer Villaruz, Liza C.; Cobo, Manuel; Syrigos, Konstantinos; Mavroudis, Dimitrios; Zhang, Wei; Kim, Jong Seok; Socinski, Mark A. LUNG CANCER 0169-5002 (2019) DOI / 10.1016/j.lungcan.2019.08.009
Mentions   0   Wikipedia   0   News   0   Policy
Review PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis Majem, Margarita; Cobo, Manuel; Isla, Dolores; Marquez-Medina, Diego; Rodriguez-Abreu, Delvys; Casal-Rubio, Joaquin; Moran-Bueno, Teresa; Bernabe-Caro, Reyes; Perez-Parente, Diego; Ruiz-Gracia, Pedro; Arroyo, Marta Marina; Paz-Ares, Luis JOURNAL OF CLINICAL MEDICINE (2021) DOI / 10.3390/jcm10071365 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER Goldman, Jonathan W.; Mazieres, Julien; Barlesi, Fabrice; Dragnev, Konstantin H.; Koczywas, Marianna; Goskel, Tuncay; Cortot, Alexis B.; Girard, Nicolas; Wesseler, Claas; Bischoff, Helge; Nadal, Ernest; Park, Keunchil; Lu, Shun; Taus, Alvaro; Cobo, Manuel; FRONTIERS IN ONCOLOGY 2234-943X (2020) DOI / 10.3389/fonc.2020.578756 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3) Forster, Martin; Hackshaw, Allan; De Pas, Tommaso; Cobo, Manuel; Garrido, Pilar; Summers, Yvonne; Dingemans, Anne-Marie C.; Flynn, Michael; Schnell, David; von Wangenheim, Ute; Loembe, Arsene-Bienvenu; Kaiser, Rolf; Lee, Siow Ming LUNG CANCER 0169-5002 (2018) DOI / 10.1016/j.lungcan.2018.03.007 Gold other, Green published

Más rankings

InfluScience

Contacto
Cerrar